trending Market Intelligence /marketintelligence/en/news-insights/trending/gupr7ogc9kw-cwyxz0kgeq2 content esgSubNav
In This List

Arcturus Therapeutics terminates CEO, appoints interim president

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Arcturus Therapeutics terminates CEO, appoints interim president

Arcturus Therapeutics Ltd. said its board decided to terminate the employment of President and CEO Joseph Payne.

The company said the decision is not related to the biotechnology company's operational performance, ongoing programs, financial condition or financial reporting.

Arcturus has named Mark Herbert as interim president, effective Feb. 2. Herbert joined the company in 2015 and most recently was vice president of business development and alliance management.